Note: Ingredients listed on restricted chemical lists
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
>99 1221-04 <0.2 <0.1
EC/CAS
247-852-1/26628-22-8
Name of the chemical
Sodium Azide
Concentration
N/A
EC/CAS
231-555-9/7632-00-0
Name of the chemical
Sodium nitrite
Concentration
<0.02
EC/CAS
200-580-7/64-19-7
Name of the chemical
acetic acid
Concentration
<0.01
General Information
Revision date
2008-11-13
Product name
Strep A QC Control
1.2.1 Relevant identified uses
For external quality control testing. For In Vitro Diagnostic Use Only Description: Aqueous solution containing heat-inactivated antigen, albumin, and preservative Corporate Headquarters
Emergency telephone
800-424-9300, 703-527-3887
Icons in SDS
Company Information
company name
Genzyme Corporation
Section 2
SECTION 2: Hazards identification
Directive 1999/45/EC: .
Precautionary statements
CAUTION! The chemical, physical and toxicological properties of this preparation have not been thoroughly characterized. Avoid contact with eyes and skin. Do not ingest or inhale. Harmful by ingestion. Preparation appearance: clear, colorless liquid.
Principle Routes of Exposure
Occupational exposure routes may include eye contact, skin contact and skin absorption.
Potential health effects
Inhalation Aerosol inhalation may cause coughing and sore throat. Eye Eye exposure may cause irritation, redness and watering. Skin Skin contact may cause irritation, dryness and redness. Sodium azide may be absorbed through the skin and result in systemic effects. Ingestion Ingestion of sodium azide may cause nausea, diarrhea, vomiting, headache, slight lowering of blood pressure, abdominal pain, and a general feeling of apprehension and unwellness.
Potential chronic health
No data available. Target Organs Sodium azide: Cardiovascular and central nervous system. Regulatory Status
Environmental effects
Unknown.